168 related articles for article (PubMed ID: 11762039)
1. [Immunotherapy for hepatocellular carcinoma using dendritic cells].
Homma S; Toda G; Ohno T
Nihon Rinsho; 2001 Oct; 59 Suppl 6():693-8. PubMed ID: 11762039
[No Abstract] [Full Text] [Related]
2. [Immunotherapy of hepatocellular carcinoma].
Geissler M; Mohr L; Blum HE
Dtsch Med Wochenschr; 2001 Dec; 126(51-52):1464-6. PubMed ID: 11753738
[No Abstract] [Full Text] [Related]
3. Comparative analysis of DC fused with allogeneic hepatocellular carcinoma cell line HepG2 and autologous tumor cells as potential cancer vaccines against hepatocellular carcinoma.
Cao DY; Yang JY; Yue SQ; Tao KS; Song ZS; Wang DS; Yang YL; Dou KF
Cell Immunol; 2009; 259(1):13-20. PubMed ID: 19545862
[TBL] [Abstract][Full Text] [Related]
4. [Immune therapy against hepatocellular carcinoma using gene-modified tumor cells].
Miyagi T; Tatsumi T; Hayashi N
Nihon Rinsho; 2001 Oct; 59 Suppl 6():688-92. PubMed ID: 11762038
[No Abstract] [Full Text] [Related]
5. Dendritic cell as therapeutic vaccines against tumors and its role in therapy for hepatocellular carcinoma.
Sun K; Wang L; Zhang Y
Cell Mol Immunol; 2006 Jun; 3(3):197-203. PubMed ID: 16893500
[TBL] [Abstract][Full Text] [Related]
6. [Current status of immuno-gene therapy for hepatocellular carcinoma].
Ye S
Zhonghua Gan Zang Bing Za Zhi; 2002 Dec; 10(6):407-8. PubMed ID: 12502436
[No Abstract] [Full Text] [Related]
7. Comparative analysis of DC fused with tumor cells or transfected with tumor total RNA as potential cancer vaccines against hepatocellular carcinoma.
Zhang HM; Zhang LW; Liu WC; Cheng J; Si XM; Ren J
Cytotherapy; 2006; 8(6):580-8. PubMed ID: 17148035
[TBL] [Abstract][Full Text] [Related]
8. Immune therapy for liver cancer.
Harrington M
Lab Anim (NY); 2014 Aug; 43(8):257. PubMed ID: 25050714
[No Abstract] [Full Text] [Related]
9. Potential of immunotherapy for hepatocellular carcinoma.
Breous E; Thimme R
J Hepatol; 2011 Apr; 54(4):830-4. PubMed ID: 21145836
[TBL] [Abstract][Full Text] [Related]
10. Immunobiology and gene-based immunotherapy of hepatocellular carcinoma.
Geissler M; Mohr L; Ali MY; Grimm CF; Ritter M; Blum HE
Z Gastroenterol; 2003 Nov; 41(11):1101-10. PubMed ID: 14648380
[TBL] [Abstract][Full Text] [Related]
11. [Current status and progress of immunotherapy for hepatocellular carcinoma].
Yang DH
Zhonghua Gan Zang Bing Za Zhi; 2003 Dec; 11(12):757. PubMed ID: 14697145
[No Abstract] [Full Text] [Related]
12. Induction of specific cytolytic T lymphocytes using fusions of hepatocellular carcinoma (HCC) patient-derived dendritic cells and allogeneic HCC cell line.
Yin XY; Wang L; Lu MD; Li BJ; Huang JF
Hepatogastroenterology; 2008; 55(81):155-9. PubMed ID: 18507097
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of hepatocellular carcinoma.
Korangy F; Höchst B; Manns MP; Greten TF
Expert Rev Gastroenterol Hepatol; 2010 Jun; 4(3):345-53. PubMed ID: 20528121
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-12 gene therapy for hepatocellular carcinoma: a dream come true?
Tsai SL
J Gastroenterol Hepatol; 2004 Oct; 19(10):1097-100. PubMed ID: 15377285
[No Abstract] [Full Text] [Related]
15. Immunotherapy of hepatocellular carcinoma with a vaccine based on xenogeneic homologous alpha fetoprotein in mice.
Zhang W; Liu J; Wu Y; Xiao F; Wang Y; Wang R; Yang H; Wang G; Yang J; Deng H; Li J; Wen Y; Wei Y
Biochem Biophys Res Commun; 2008 Nov; 376(1):10-4. PubMed ID: 18725206
[TBL] [Abstract][Full Text] [Related]
16. [Initial research of the effect and mechanism of cytotoxic T lymphocyte (lymphocyte) primed by dendritic cell as hepatocellular carcinoma vaccine].
Guo JW; Qin LW; Cai MY; Guo YB; Lu TD; Yu L
Zhonghua Gan Zang Bing Za Zhi; 2003 Jul; 11(7):414, 417. PubMed ID: 12890344
[No Abstract] [Full Text] [Related]
17. [Dendritic cells and immunotherapy of liver cancer].
Cao XT
Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):133-4. PubMed ID: 12681054
[No Abstract] [Full Text] [Related]
18. Autoimmune hepatic inflammation by vaccination of mice with dendritic cells loaded with well-differentiated hepatocellular carcinoma cells and administration of interleukin-12.
Tamaki S; Homma S; Enomoto Y; Komita H; Zeniya M; Ohno T; Toda G
Clin Immunol; 2005 Dec; 117(3):280-93. PubMed ID: 16246626
[TBL] [Abstract][Full Text] [Related]
19. Immune responses in hepatocellular carcinoma.
Korangy F; Höchst B; Manns MP; Greten TF
Dig Dis; 2010; 28(1):150-4. PubMed ID: 20460904
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy for hepatocellular carcinoma.
Li S; Yang F; Ren X
Drug Discov Ther; 2015 Oct; 9(5):363-71. PubMed ID: 26632545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
